LINDSAY SEDDON: Open Payments
NPI 1942500343 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,619 in 122 payments from 19 companies in 2025. Trend: 2023 $2,449 · 2024 $3,093 · 2025 $2,619
Food & beverage: $2,531Education: $88
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $597 |
| Janssen Biotech, Inc. | 15 | $318 |
| Regeneron Healthcare Solutions, Inc. | 10 | $231 |
| Novartis Pharmaceuticals Corporation | 9 | $211 |
| Amgen Inc. | 9 | $211 |
| Hill Dermaceuticals, Inc. | 1 | $170 |
| E.R. Squibb & Sons, L.L.C. | 10 | $166 |
| GENZYME CORPORATION | 7 | $162 |
| Organon LLC | 4 | $77 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $71 |
Products named: DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, Otezla, Tolak, Sotyktu, Rhapsido.
Industry payments across VA — which companies pay providers there.
